In case of cervical adenocarcinomas, there are reports that conclude that amplification of HER2 and mutations in TP53 are rare in cervical adenocarcinomas and that, low level chromosome 17q copy number gains are not associated with HER2 over-expression [29]. Here, TP53 is linked to cervical adenocarcinoma.